What is Beam Therapeutics's common stock?

Beam Therapeutics (BEAM) reported common stock of $1.03M in Q1 2026.

How has Beam Therapeutics's common stock changed year-over-year?

Beam Therapeutics's common stock increased by 2.1% year-over-year, from $1.01M to $1.03M.

What is the long-term trend for Beam Therapeutics's common stock?

Over 5 years (2020 to 2025), Beam Therapeutics's common stock has grown at a 12.2% compound annual growth rate (CAGR), from $573K to $1.02M.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Beam Therapeutics BEAM Common Stock

Common Stock at other companies

Arrowhead ResearchARWR

$236K+2.6%

CRISPR TherapeuticsCRSP

$3.12M+14.5%

Cogent Biosciences, Inc.COGT

$171K+50.0%

PTC TherapeuticsPTCT

$81K+3.8%

BridgeBio PharmaBBIO

500M+253,707%

Protagonist TherapeuticsPTGX

$1K0.0%

Other financials

Income statement

See full

Revenue$31.7M+325%

Operating income-$107.2M+10.1%

Net income-$94.3M+12.9%

EPS (diluted)-$0.91+26.0%

Balance sheet

See full

Cash & equivalents$288.3M-45.4%

Total debt$250.8M+58.6%

Total equity$1.2B+3.1%

Total assets$1.5B+0.9%

Cash flow

See full

Operating cash flow-$128.5M-23.7%

CapEx$2.2M-27.2%

Free cash flow-$130.7M-22.2%

Valuation

See full

Market cap$3.51B+24.5%

Enterprise value$3.47B+51.2%

P/S21.4×-23.0×

Profitability

See full

Operating margin-226.6%-90.5pp

Net margin-742.7%—

FCF margin-234%-86.6pp

Returns & leverage

See full

Return on equity-47.1%—

Debt / equity0.2×+0.1×

Current ratio17×+8.2×

Where this comes from

Reported directly by Beam Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Beam Therapeutics's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Beam Therapeutics's common stock?: Beam Therapeutics (BEAM) reported common stock of $1.03M in Q1 2026.
How has Beam Therapeutics's common stock changed year-over-year?: Beam Therapeutics's common stock increased by 2.1% year-over-year, from $1.01M to $1.03M.
What is the long-term trend for Beam Therapeutics's common stock?: Over 5 years (2020 to 2025), Beam Therapeutics's common stock has grown at a 12.2% compound annual growth rate (CAGR), from $573K to $1.02M.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).